Accredo offers a wide range of medications to treat various complex and chronic conditions. Visit Conditions to learn more about treatment, medications, and support for your condition.
| Medication | Condition(s) | Generic/Biosimilar | Manufacturer |
|---|---|---|---|
| Adynovate®(antihemophilic factor [recombinant], PEGylated) |
Bleeding disorders
|
Takeda Pharmaceuticals | |
| Afinitor® (everolimus) |
Brain cancer
Breast cancer
Gastrointestinal cancer
Kidney cancer
Lung cancer
Pancreatic cancer
|
Novartis Pharmaceuticals Corp. | |
| Afstyla® (antihemophilic factor [recombinant], single chain) | CSL Behring, LLC | ||
| Aldurazyme® (laronidase) |
Enzyme deficiencies
Hurler & Hurler-Scheie (MPSI)
|
Genzyme Corporation | |
| Alecensa® (alectinib) | Genentech USA, Inc. | ||
| Alhemo™ (concizumab-mtci) | Novo Nordisk | ||
| Alphanate® (antihemophilic factor/VWF complex [human]) | Grifols | ||
| AlphaNine® SD (coagulation factor IX [human]) |
Bleeding disorders
|
Grifols | |
| Alprolix™ (coagulation factor IX [recombinant], fc fusion protein) |
Bleeding disorders
|
Sanofi | |
| Altuviiio™ [antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl] | Sanofi |